Danaher Corporation (DHR)
| Previous close | 247.40 |
| Open | 246.54 |
| Bid | 247.50 x 900 |
| Ask | 247.57 x 800 |
| Day's range | 246.20 - 248.40 |
| 52-week range | 182.09 - 259.00 |
| Volume | |
| Avg. volume | 2,586,200 |
| Market cap | 183.024B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 45.42 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.08 (0.44%) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
- PR Newswire
Danaher Reports First Quarter 2024 Results
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted.
- PR Newswire
Danaher Schedules First Quarter 2024 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.
